Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize
Advertisement
Cheng Lyu, PhD., Postdoctoral Fellow at Stanford University, California, USA, wins the Eppendorf & Science Prize for Neurobiology for his work on rewiring the olfactory neural circuit in fruit flies.
“Cheng Lyu’s winning essay describes the molecular mechanisms how olfactory receptor neurons choose one synaptic partner out of all potential candidates” said Peter Stern, Senior Editor at SCIENCE and Prize Jury Chair. “These results provide a profound understanding of the principles of neural circuit assembly.”
“We found that the fly olfactory neural circuit builds its three-dimensional structure by breaking the developmental task into a series of one-dimensional steps”, says Lyu. “By manipulating this process, we rewired the neural circuit and altered the animal’s courtship behavior.”
These findings link genetic variation, through circuit assembly, to animal behavior, paving the way to explore how developmental changes influence brain function.
Two finalists are also recognized. Constanze Depp, Ph.D., Postdoctoral Fellow at the Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA, for examining the role of myelin and oligodendrocytes in Alzheimer’s disease, and Sara Mederos, Ph.D., Wellcome Early Career Fellow at the Sainsbury Wellcome Centre, London, United Kingdom, for revealing how the brain learns to adapt fear responses and be able to suppress them.
The prize will be presented on November 16, 2025 in San Diego, USA, during the week of the Society for Neuroscience.
Eppendorf and the journal Science are awarding this prestigious prize since 2002. Since it’s initiation, the Prize has acknowledged over 70 winners and finalists, brilliant young talents at an early stage of their careers.
Other news from the department science
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration - Agreement to take on real-world challenges in biologics and materials research
New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments
CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines - Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need
First-of-its-kind vaccine expands malaria protection for pregnant women - Sanaria® PfSPZ Vaccine protects women against malaria before and during pregnancy for at least two years
Bayer awards incubator opportunity to Genvor - Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
Merck and Washington University in St. Louis Sign MoU to Advance Scientific Collaboration - Strategic academic-industry alliance aims to build robust Research & Development talent pipeline
Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina - Facility designed to advance the next generation of imaging systems
QUANTRO Therapeutics extends collaboration with Boehringer Ingelheim - Novel targets in oncology
Giles introduces AI agent to accelerate healthcare and life science research - AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articles
Faster and more reliable crystal structure prediction of organic molecules